CA2003340A1 — Pharmaceutical compositions
Assigned to F Hoffmann La Roche AG · Expires 1990-05-22 · 36y expired
What this patent protects
ABSTRACT The absorption of antibiotics given through oral and rectal routes of administration is significantly enhanced by use of the antibiotic in conjunction with a two-component absorption enhancing system made up of an ether of a C6 to C18 alcohol and a polyoxyethylene gl…
USPTO Abstract
ABSTRACT The absorption of antibiotics given through oral and rectal routes of administration is significantly enhanced by use of the antibiotic in conjunction with a two-component absorption enhancing system made up of an ether of a C6 to C18 alcohol and a polyoxyethylene glycol together with a second component selected from among polyoxyethylene glycol-C6 to C18 glyceride esters, C6 to C18 carboxylic acids or salts thereof, and esters of two or more C6 to C18 carboxylic acids, glycerol and a polyoxyethylene glycol. A carrier and adjuvants are usually included. These compositions can be administered in any convenient oral or rectal dosage form, including tablets, capsules, beadlets and suppositories.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.